Funding & Disrupting

Keith Herman

Funder meets Founder. The road to tech funding is always filled will pitfalls. Hear directly from the VC and company founder how they met, found common ground and consummated their relationship. read less
BusinessBusiness

Episodes

Karista - A VC Firm Investing in Game Changers from Scratch to Success
Jun 29 2023
Karista - A VC Firm Investing in Game Changers from Scratch to Success
Show Notes:  ●      Catherine Boule is a molecular biologist turned venture capitalist, with expertise in healthcare, market, and healthcare technologies. ●      Karista's relies on internal due diligence and external expert consultation to decrease risk and develop relationships as early-stage investors in complex ideas. ●      Karista hires managers with diverse backgrounds to ensure they better understand the people they are financing. ●      Karista's exits and experience in M&A, IPOs on Euronext and NASDAQ, and even a rare occurrence of management buyback. ●      Expectations for tech companies seeking VC funding include being prepared to share power and strategy with investors, establishing trust with VC partners, and finding investors who share their company's vision. Background: Catherine Boule is a Molecular biologist who previously worked as a Scientific Researcher at Institut Curie. However, she realized that she did not want to spend her entire career in the lab and was advised to gain some business experience. To this end, she pursued an MBA, which opened up a whole new world outside of her lab work. At that time, there were very few VC firms in France, and Catherine's first job was as a Project Manager for Life Sciences at IDFI Incubator, now known as Incuballiance. Later on, she joined Karista VC firm, where her expertise in healthcare, market, and healthcare technologies was highly valued.Karista’s Portfolio:Karista, a Paris-based firm, has been operating for 21 years with a team spread across France, the UK, Portugal, and Spain. Initially, they invested in a broad range of high-tech companies including healthcare and digital, through a generalist fund. However, now they specialize in deep tech and space tech.Karista’s Exits:Karista has had around 25 exits with experience in many different outcomes. They have dealt with M&As in Europe, the US, and Asia, as well as IPOs on Euronext and NASDAQ. While they prefer M&A, they were also seed investors in three of the six French biotech companies listed on NASDAQ. In a rare occurrence, they even had one company where the management bought back the company.What should tech companies expect when they get VC for the first time?When seeking VC funding, it's important to be prepared to share power and strategy with the investors. Karista won't invest if they can't have a say in the direction of the company. Founders need to establish trust with their VC partners because investors are investing in the dreams and visions of entrepreneurs. Connect With Catherine:You can get in contact with Catherine and Karista via email: Catherine.Boule@Karista.VC Connect With Funding and Disrupting:Follow us on LinkedIn or TwitterApply to be a guest on the showSubscribe to our email listConnect with the show on Twitter, LinkedIn, and YouTube
Tim Flannery: CEO & Co-Founder of PassThrough
Apr 26 2023
Tim Flannery: CEO & Co-Founder of PassThrough
Tim Flannery co-founded Passthrough and currently serves as its CEO. He's known for his entrepreneurial spirit and competitive drive. In his 30s, he took up rugby and now enjoys playing the sport with his two children and his work. Show Notes: ●      Working as a VC exposed Tim to different business models and leadership styles, but he realized he enjoyed building things more than investing in them.●      Passthrough was created to solve the problem in the onboarding process of venture firms. They developed a solution that makes it easier for people to invest in venture funds quickly, and they are now helping around 250 fund managers. ●      Passthrough bootstrapped its business and raised $5 million in seed funding in 2021, followed by another round of $10 million in 2022. ●      Positive Sum, an investor in Passthrough, has a large network and takes a hands-on approach that has been invaluable to Passthrough. They also provide a highly effective distribution channel through Patrick O'Shaughnessy's podcast "Invest like the Best."Passthrough - Automates The Subscription Process For Private Funds. Focusing on Less Time Spent Going Back and Forth, Better Compliance, and Structured Investor DataCheck the podcast for:• Tim's Entrepreneurship Path to Passthrough• What Tim Learned in VC and Why He Transition to Founder• Passthrough Overview• Passthrough's Capital Raising Experience• Passthrough's Initial Interactions with Positive Sum• Other Ways Positive Sum Supports Passthrough• No two Investors are the Same• Advice for Vetting and Connecting to Partners• The Plan to Scale Passthrough Currently, Passthrough is providing fund closing services for fund managers, and their goal is to become their go-to option. However, they also see potential opportunities in serving enterprise and API customers. Over the next few years, they'll explore these avenues and figure out how to scale them. Connect With Tim: You can get in contact with Tim and Passthrough via email: sales@passthrough.comConnect With Funding and Disrupting: Follow us on LinkedIn or TwitterApply to be a guest on the showSubscribe to our email listConnect with the show on Twitter, LinkedIn, and YouTube
Upland Attracts C3 Ventures to the Metaverse
Oct 13 2022
Upland Attracts C3 Ventures to the Metaverse
Upland was founded in 2018 by serial entrepreneurs Dirk Lueth, Idan Zuckerman and Mani Honigstein they raised $18M on $300M Series A in October 2021. The team includes 130 members since their launched in early 2020. They reached profitable in 2021 as one of the largest blockchain-based metaverse mapped to the real world with over 280k "landowners" with various game engagement points; sold over 4M NFTs. It started as a "property trading game" (think Monopoly) and evolved today into a platform where creators, developers, and brands launch their own experiences and applications (think "iOS" for the metaverse).Upland is also the entrepreneurial metaverse where e.g. players can create and run their own ventures like selling "outside decor" and other creations. It is currently live in 20 US cities, Rio de Janeiro and Porto (Portugal) and available on Mobile and Web. They have partnerships with NFLPA, FC Porto, Hyperloop, and others.Co-founder, Dirk Lueth, is also the author of the Amazon bestseller book "Navigating the Metaverse"; initiator and co-founder of the Open Metaverse Alliance for Web3 oma3.org. Upland is turning from a game into a platform that is launching its 3rd party developer portal this week. Upland attracted investment from C3 Venture Capital (“C3”) a venture capital company focused on managing early-stage venture funds which invest in exceptional technology companies worldwide. C3‘s mission is, among other things, to accelerate growth, development and especially adoption of blockchain technology. Connect with the show on Twitter, LinkedIn, and YouTube
Disruption in Surgical Care with Dr. Sanjay Prasad, Founder & CEO of SurgiQuality
Sep 22 2021
Disruption in Surgical Care with Dr. Sanjay Prasad, Founder & CEO of SurgiQuality
This week’s episode of Funding & Disrupting presented by Oura Collective welcomes Sanjay Prasad. He is a brilliant surgeon with over 30 years of experience and the Founder & CEO of SurgiQuality. Sanjay is also an Assistant Professor at George Washington University and an Author. With so much experience and expertise, Sanjay always looks for ways to achieve more than himself. Keith interviews Sanjay to know more about his unique healthcare platform named SurgiQuality. What led to the idea of SurgiQuality?In the interview, Keith asks Sanjay about his observations in regards to surgeries these days. Sanjay candidly shares how most people are not much aware of the right surgeries. He talks about how people undergo some surgeries that they never needed. Also, some people connect to surgeons who rarely offer the best outcomes. All such problems of patients develop complications, and they may need even more surgeries. Sanjay feels that the healthcare sector needs more accountability today. Did you know 15-25% of surgical procedures performed today are unnecessary?Sanjay felt the quality of work was missing. He thought, “How do patients get to the right surgeon who has the best outcomes?” and it is where the idea of SurgiQuality came.How SurgiQuality works?To get a deeper insight into the platform, Keith asks Sanjay about the primary problems that SurgiQuality solves. Sanjay shares that the prime problem SurgiQuality disrupts and improves drastically is getting referrals from primary-care physicians to surgeons. Most of the time, primary doctors do not have the best information about the surgeons. It is where SurgiQuality helps primary doctors with referrals.Sanjay elaborates how SurgiQuality works. And according to Sanjay, everyone wins with the use of SurgiQuality. Patients get the best surgeons, and the quality of surgery improves. The surgeons get the patients in their area of interest and expertise. Moreover, primary doctors can give better referrals. So, it is a win-win for all.How did the funding process go?In the next segment, Keith asks Sanjay about the partnerships and the funding method followed by SurgiQuality. Sanjay shares that SurgiQuality has partnered with over 30,000 surgeons in 50 states. They have contacts with 300 surgery centers and hospitals. Talking about funding, Sanjay shares how he started the idea in 2014 with a small team of people. He also mentions how he invested heavily into it. Today, SurgiQuality is in series A-round raising 5 million for sales, marketing and customized technology for SurgiQuality.Sanjay also talks about what they look for in an ideal investor. He also talks about partnering with VC firms that bring contracts and connections.Sanjay Also Provides Life-changing Advises for Patients & ProfessionalsStory Notes:What motivates Sanjay?Experience & observations in surgeriesProblems solved by SurgiQualityWho can benefit?Partnerships & FundingAdvice for transforming healthcareThank you for joining us on this episode of Funding & Disrupting. Don't forget to visit our sponsor OuraCo.com to learn more about working directly with OURA Collective's exclusive technology PR team. They'll help you craft your message, get noticed in the press, and help you get your venture to the funding finish line.Again you can visit them at Connect with the show on Twitter, LinkedIn, and YouTube